Replay available

NeoGenomics, Inc. (NEO) Q1 2026 Earnings Call

NeoGenomics, Inc. (NASDAQ: NEO) Q1 2026 earnings conference call, held 2026-04-28. Replay captured from the company's public earnings webcast.

Tue, April 28, 2026 at 4:30 PMendedReplay
NeoGenomics, Inc. (NEO) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Priya Viduraman

Senior Vice President of Finance

Tony Zook

Chief Executive Officer

Warren Stone

President and Chief Operating Officer

Abhishek Jain

Chief Financial Officer

David Westenberg

Analyst, Piper Sandler

Tycho Peterson

Analyst, Jefferies

Puneet Soda

Analyst, Leerink

Bill Bonella

Analyst, Craig-Hallum

Subbu Nabi

Analyst, Guggenheim

Dan Brennan

Analyst, TD Cowen

Michael Reiskin

Analyst, Bank of America

Mike Madsen

Analyst, Needham & Company

Replay transcript excerpt

Good afternoon, and welcome to the Neogenomics First Quarter 2026 Financial Results Call. Please be advised that today's conference is being recorded. I will now turn the call over to Priya Viduraman, Senior Vice President of Finance. Thank you, Matthew, and good afternoon, everyone. Welcome to Neogenomics First Quarter 2026 Financial Results Call. With me today to discuss the results are Tony Zook, Chief Executive Officer of Abhishek Jain, Chief Financial Officer, and Warren Stone, President and Chief Operating Officer. Additional members of the management team will be available for the Q&A portion of our call. This call is being simultaneously webcast. You will know that we will be advancing through a brief slide presentation to accompany today's call, and we have also made the presentation available on the investor tab of our website at ir.neogenomics.com. During this call, we will make forward-looking statements regarding our future financial and business performance, planned future operations, and related expectations with respect to timing and performance, future financial position, future revenue, growth potential, and expected growth drivers, projected cost and capital expenditure, prospects and plans, estimated market size and position, and objectives of management and financial guidance. We caution you that the actual events or results could differ materially from those expressed or implied by the forward-looking statements. These forward-looking statements made during the call speak only as of the original date of this call, and we undertake no obligation to update or revise any of these statements. Please refer to the information disclosed on the Safe Harbor Statement slide in the deck posted on our website, as well as the information under the heading Ri...

More from Neogenomics, Inc.